Society guideline links: Atrial fibrillation

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Arrhythmias in adults" and "Society guideline links: Heart failure in adults" and "Society guideline links: Myocarditis" and "Society guideline links: Acute extremity ischemia" and "Society guideline links: Intestinal ischemia".)

International

●International Society on Thrombosis and Haemostasis (ISTH): Guidance for the anticoagulation of cancer patients with non‐valvular atrial fibrillation receiving chemotherapy (2019)

●Heart Rhythm Society (HRS)/European Heart Rhythm Association (EHRA)/European Cardiac Arrhythmia Society (ECAS)/Asian Pacific Heart Rhythm Society (APHRS)/Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE): Expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017)

●Society of Thoracic Surgeons (STS): Clinical practice guidelines for the surgical treatment of atrial fibrillation (2017)

Canada

●Canadian Cardiovascular Society (CCS): Management of atrial fibrillation, focused update (2018)

●CCS: Atrial fibrillation guidelines – Recommendations for stroke prevention and rate/rhythm control, focused update (2012)

United States

●American College of Cardiology (ACC)/American Heart Association (AHA): 2020 update to the 2016 clinical performance and quality measures for adults with atrial fibrillation or atrial flutter (published 2021)

●AHA: Scientific statement on managing atrial fibrillation in patients with heart failure and reduced ejection fraction (2021)

●ACC/AHA: Guideline for the management of patients with valvular heart disease (2020)

●AHA/ACC/Heart Rhythm Society (HRS): Guideline for the management of patient with atrial fibrillation, focused update (2019)

●American College of Chest Physicians (CHEST): Guideline and expert panel report on antithrombotic therapy for atrial fibrillation (2018)

●HRS/European Heart Rhythm Association (EHRA)/European Cardiac Arhythmia Society (ECAS)/Asian Pacific Heart Rhythm Society (APHRS)/Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE): Expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017)

●ACC/AHA: Clinical performance and quality measures for adults with atrial fibrillation or atrial flutter (2016)

●North American Thrombosis Forum (NATF): AF action initiative consensus document (2016)

●Society for Cardiovascular Angiography and Interventions (SCAI)/ACC/HRS: Expert consensus document on institutional and operator requirements for left atrial appendage occlusion (2016)

●ACC/HRS/SCAI: Left atrial appendage occlusion device societal overview (2015)

●Choosing Wisely: Don't ablate the atrioventricular node in patients with atrial fibrillation when both symptoms and heart rate are acceptable controlled by well-tolerated medical therapy (2014)

Europe

●European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS): Guidelines for the management of atrial fibrillation (2020)

●European Heart Rhythm Association (EHRA): Practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation (2018)

●EHRA, European Association of Percutaneous Coronary Intervention (EAPCI), and Acute Cardiovascular Care Association (ACCA): Joint European consensus document on management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions (2018)

●EHRA/European Association of Cardiovascular Prevention and Rehabilitation (EACPR): Position paper on how to prevent atrial fibrillation (2017)

●Heart Rhythm Society (HRS)/EHRA/European Cardiac Arrhythmia Society (ECAS)/Asian Pacific Heart Rhythm Society (APHRS)/Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE): Expert consensus statement on catheter and surgical ablation of atrial fibrillation (2017)

●European Primary Care Cardiovascular Society (EPCCS): Consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care, 2015 (published 2016)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on atrial fibrillation – Diagnosis and management (2021)

●NICE: Diagnostics guidance on implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke (2020)

●NICE: Diagnostics guidance on lead-I ECG devices for detecting symptomatic atrial fibrillation using single time point testing in primary care (2019)

●NICE: Quality standard on atrial fibrillation (2015, updated 2018)

●NICE: Diagnostics guidance on atrial fibrillation and heart valve disease – Self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) (2014, updated 2017)

●NICE: Interventional procedures guidance on percutaneous endoscopic laser balloon pulmonary vein isolation for atrial fibrillation (2016)

●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on antithrombotics – Indications and management (2012, updated 2013)

●NICE: Interventional procedures guidance on percutaneous balloon cryoablation for pulmonary vein isolation in atrial fibrillation (2012)

Australia-New Zealand

●National Heart Foundation of Australia (NHRA) and the Cardiac Society of Australia and New Zealand (CSANZ): Australian clinical guidelines for the diagnosis and management of atrial fibrillation (2018)

●National Heart Foundation of Australia (NHFA): Consensus statement on catheter ablation as a therapy for atrial fibrillation (2013)